The American Medical Association (AMA) released the Category I vaccine product codes for monkeypox tests and vaccines. The organization made them effective immediately upon their approval by the CPT Editorial Panel on July 26.
On August 1, CMS issued its fiscal year (FY) 2023 Inpatient Prospective Payment System (IPPS) final rule, applying to discharges occurring on or after October 1, 2022.
Federal price transparency regulations are forging ahead with the help of state-level reinforcements like Colorado’s HB 22-1285. The act prohibits a hospital from collecting a patient’s debt if their charges were acquired on a date when the hospital was noncompliant with the CMS price transparency requirements.
The 2023 Inpatient Prospective Payment System (IPPS) final rule, which takes effect October 1, includes updates to payment rates, MS-DRGs, and a number of quality and reporting programs.
CMS is weighing an expansion of the hospital outpatient department prior authorization program, changes to 340B reimbursement in the wake of the Supreme Court’s decision, and alternative rate setting data among other proposals in the 2023 Outpatient Prospective Payment System (OPPS) proposed rule.
Payment cuts are in the offing for Part B providers in 2023, along with a series of other projected changes targeting E/M services, COVID-19-related billing flexibilities, and value-based care, according to the 2023 Medicare Physician Fee Schedule (MPFS) proposed rule released July 7.
The American Medical Association’s (AMA) CPT Editorial Panel recently published changes to its evaluatio and management (E/M) Services Guidelines. The update includes code revisions, additions, and deletions, which are scheduled to take effect January 1, 2023.
Roughly half of hospitals did not adhere to provisions of the Hospital Price Transparency rule that require them to post five types of standard charges for all services in a machine-readable file and a separate consumer-friendly file or price estimator for at least 300 shoppable services, according to a recent JAMA study.
The Supreme Court ruled that HHS’ failure to survey hospital costs before enacting the cuts exceed the agency’s authority under the Medicare statute, making the decision to reduce 340B reimbursement unlawful.
